{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T13:45:47Z","timestamp":1772027147766,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:00:00Z","timestamp":1727827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:00:00Z","timestamp":1727827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-73278-y","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T08:02:23Z","timestamp":1727856143000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["RETRACTED ARTICLE: Serum melatonin levels and in a sample of Iranian patients with migraine"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9368-6835","authenticated-orcid":false,"given":"Mansoureh","family":"Togha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1971-8982","authenticated-orcid":false,"given":"Morvarid","family":"Noormohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4230-5710","authenticated-orcid":false,"given":"Zeinab","family":"Ghorbani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8805-3486","authenticated-orcid":false,"given":"Fariba","family":"Karimzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2529-045X","authenticated-orcid":false,"given":"S. Zahra","family":"Bathaie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,2]]},"reference":[{"issue":"Suppl 1","key":"73278_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/head.13301","volume":"58","author":"R Agosti","year":"2018","unstructured":"Agosti, R. Migraine burden of disease: From the patient\u2019s\nexperience to a socio-economic view. Headache58(Suppl 1),\n17\u201332. https:\/\/doi.org\/10.1111\/head.13301 (2018).","journal-title":"Headache"},{"key":"73278_CR2","unstructured":"Pescador Ruschel, M. A. & De Jesus, O. In StatPearls (StatPearls Publishing Copyright\n\u00a9 2024, StatPearls Publishing LLC, 2024)."},{"key":"73278_CR3","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/S1474-4422(18)30322-3","volume":"17","author":"L Stovner","year":"2018","unstructured":"Stovner, L. et al. Global,\nregional, and national burden of migraine and tension-type headache,\n1990\u20132016: A systematic analysis for the global burden of disease study\n2016. Lancet Neurol.17, 954\u2013976. https:\/\/doi.org\/10.1016\/S1474-4422(18)30322-3 (2018).","journal-title":"Lancet Neurol."},{"key":"73278_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s10194-017-0787-1","volume":"18","author":"D Serrano","year":"2017","unstructured":"Serrano, D. et al. Fluctuations\nin episodic and chronic migraine status over the course of 1 year: Implications\nfor diagnosis, treatment and clinical trial design. J.\nHeadache Pain18, 101. https:\/\/doi.org\/10.1186\/s10194-017-0787-1 (2017).","journal-title":"J. Headache Pain"},{"key":"73278_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2022.148100","volume":"1797","author":"M Togha","year":"2022","unstructured":"Togha, M. et al. Proteomics\nanalysis revealed the presence of inflammatory and oxidative stress markers in\nthe plasma of migraine patients during the pain period. Brain Res.1797, 148100. https:\/\/doi.org\/10.1016\/j.brainres.2022.148100 (2022).","journal-title":"Brain Res."},{"key":"73278_CR6","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1111\/head.12174","volume":"53","author":"P Durham","year":"2013","unstructured":"Durham, P. & Papapetropoulos, S. Biomarkers associated with\nmigraine and their potential role in migraine management. Headache53,\n1262\u20131277. https:\/\/doi.org\/10.1111\/head.12174 (2013).","journal-title":"Headache"},{"key":"73278_CR7","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/s1474-4422(17)30435-0","volume":"17","author":"A Charles","year":"2018","unstructured":"Charles, A. The pathophysiology of migraine: Implications for\nclinical management. Lancet Neurol.17, 174\u2013182. https:\/\/doi.org\/10.1016\/s1474-4422(17)30435-0 (2018).","journal-title":"Lancet Neurol."},{"key":"73278_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s10194-019-1066-0","volume":"20","author":"AP Andreou","year":"2019","unstructured":"Andreou, A. P. & Edvinsson, L. Mechanisms of migraine as a\nchronic evolutive condition. J. Headache\nPain20, 117. https:\/\/doi.org\/10.1186\/s10194-019-1066-0 (2019).","journal-title":"J. Headache Pain"},{"key":"73278_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.770980","volume":"12","author":"M Togha","year":"2021","unstructured":"Togha, M., Ghorbani, Z., Ramazi, S., Zavvari, F. &\nKarimzadeh, F. Evaluation of serum levels of transient receptor potential cation\nchannel subfamily V member 1, vasoactive intestinal polypeptide, and pituitary\nadenylate cyclase-activating polypeptide in chronic and episodic migraine: The\npossible role in migraine transformation. Front.\nNeurol.12, 770980. https:\/\/doi.org\/10.3389\/fneur.2021.770980 (2021).","journal-title":"Front. Neurol."},{"key":"73278_CR10","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/s12883-019-1555-4","volume":"19","author":"M Togha","year":"2019","unstructured":"Togha, M., Razeghi Jahromi, S., Ghorbani, Z., Ghaemi, A. &\nRafiee, P. An investigation of oxidant\/antioxidant balance in patients with\nmigraine: A case-control study. BMC\nNeurol.19, 323. https:\/\/doi.org\/10.1186\/s12883-019-1555-4 (2019).","journal-title":"BMC Neurol."},{"key":"73278_CR11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1517\/13543784.15.4.367","volume":"15","author":"MF Peres","year":"2006","unstructured":"Peres, M. F., Masruha, M. R., Zukerman, E., Moreira-Filho, C. A.\n& Cavalheiro, E. A. Potential therapeutic use of melatonin in migraine\nand other headache disorders. Expert Opin. Investig.\nDrugs15, 367\u2013375. https:\/\/doi.org\/10.1517\/13543784.15.4.367 (2006).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"73278_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s13760-016-0723-1","volume":"117","author":"HH Kozak","year":"2017","unstructured":"Kozak, H. H. et al. Sleep\nquality, morningness-eveningness preference, mood profile, and levels of serum\nmelatonin in migraine patients: A case-control study. Acta Neurol. Belg.117,\n111\u2013119. https:\/\/doi.org\/10.1007\/s13760-016-0723-1 (2017).","journal-title":"Acta Neurol. Belg."},{"key":"73278_CR13","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1046\/j.1468-2982.1995.015002136.x","volume":"15","author":"J Brun","year":"1995","unstructured":"Brun, J., Claustrat, B., Saddier, P. & Chazot, G. Nocturnal\nmelatonin excretion is decreased in patients with migraine without aura attacks\nassociated with menses. Cephalalgia15, 136\u2013139. https:\/\/doi.org\/10.1046\/j.1468-2982.1995.015002136.x (1995) (discussion\n179).","journal-title":"Cephalalgia"},{"key":"73278_CR14","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/j.1526-4610.1989.hed22904242.x","volume":"29","author":"B Claustrat","year":"1989","unstructured":"Claustrat, B. et al. Nocturnal\nplasma melatonin levels in migraine: A preliminary report. Headache29,\n242\u2013245. https:\/\/doi.org\/10.1111\/j.1526-4610.1989.hed22904242.x (1989).","journal-title":"Headache"},{"key":"73278_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1046\/j.1468-2982.1994.014003205.x","volume":"14","author":"G Murialdo","year":"1994","unstructured":"Murialdo, G. et al. Urinary\nmelatonin excretion throughout the ovarian cycle in menstrually related\nmigraine. Cephalalgia14, 205\u2013209. https:\/\/doi.org\/10.1046\/j.1468-2982.1994.014003205.x (1994).","journal-title":"Cephalalgia"},{"key":"73278_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41983-023-00670-2","volume":"59","author":"SE Fathy","year":"2023","unstructured":"Fathy, S. E., Abdallah, A. M. & Helal, R. Y. Assessment of\nserum level of melatonin in migraine: A case control study. Egypt. J. Neurol. Psychiatry Neurosurg.59, 1\u20137 (2023).","journal-title":"Egypt. J. Neurol. Psychiatry Neurosurg."},{"key":"73278_CR17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.5603\/PJNNS.a2020.0095","volume":"55","author":"A Zdu\u0144ska","year":"2021","unstructured":"Zdu\u0144ska, A., Cegielska, J., Zdu\u0144ski, S.,\nBia\u0142obrzewski, M. & Kochanowski, J. Variability in melatonin\nconcentration in blood serum of patients with episodic migraine: A pilot study.\nNeurol. Neurochir. Pol.55, 81\u201390. https:\/\/doi.org\/10.5603\/PJNNS.a2020.0095 (2021).","journal-title":"Neurol. Neurochir. Pol."},{"key":"73278_CR18","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1177\/0300060518775008","volume":"46","author":"L Lorente","year":"2018","unstructured":"Lorente, L. et al. Serum\nmelatonin levels are associated with mortality in patients with malignant middle\ncerebral artery infarction. J. Int. Med.\nRes.46, 3268\u20133277. https:\/\/doi.org\/10.1177\/0300060518775008 (2018).","journal-title":"J. Int. Med. Res."},{"key":"73278_CR19","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.2500\/aap.2023.44.230044","volume":"44","author":"A Can","year":"2023","unstructured":"Can, A. & Tuzer, O. C. The evaluation of melatonin levels in\nchronic spontaneous urticaria: A case control study. Allergy Asthma Proc.44,\ne29\u2013e35. https:\/\/doi.org\/10.2500\/aap.2023.44.230044 (2023).","journal-title":"Allergy Asthma Proc."},{"key":"73278_CR20","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1212\/01.wnl.0000134653.35587.24","volume":"63","author":"MF Peres","year":"2004","unstructured":"Peres, M. F., Zukerman, E., da Cunha Tanuri, F., Moreira, F. R.\n& Cipolla-Neto, J. Melatonin, 3 mg, is effective for migraine prevention.\nNeurology63, 757. https:\/\/doi.org\/10.1212\/01.wnl.0000134653.35587.24 (2004).","journal-title":"Neurology"},{"key":"73278_CR21","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1212\/WNL.0b013e3181f9618c","volume":"75","author":"KB Alstadhaug","year":"2010","unstructured":"Alstadhaug, K. B., Odeh, F., Salvesen, R. & Bekkelund, S. I.\nProphylaxis of migraine with melatonin: A randomized controlled trial. Neurology75,\n1527\u20131532. https:\/\/doi.org\/10.1212\/WNL.0b013e3181f9618c (2010).","journal-title":"Neurology"},{"key":"73278_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.11138\/fneur\/2016.31.1.033","volume":"31","author":"A Bougea","year":"2016","unstructured":"Bougea, A., Spantideas, N., Lyras, V., Avramidis, T. &\nThomaidis, T. Melatonin 4 mg as prophylactic therapy for primary headaches: A\npilot study. Funct. Neurol.31, 33\u201337. https:\/\/doi.org\/10.11138\/fneur\/2016.31.1.033 (2016).","journal-title":"Funct. Neurol."},{"key":"73278_CR23","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1136\/jnnp-2016-313458","volume":"87","author":"AL Gon\u00e7alves","year":"2016","unstructured":"Gon\u00e7alves, A. L. et al.\nRandomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and\nplacebo for migraine prevention. J. Neurol. Neurosurg.\nPsychiatry87, 1127\u20131132. https:\/\/doi.org\/10.1136\/jnnp-2016-313458 (2016).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"73278_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/nu14163335","volume":"14","author":"A Zdu\u0144ska","year":"2022","unstructured":"Zdu\u0144ska, A., Cegielska, J. & Domitrz, I. The\npathogenetic role of melatonin in migraine and its theoretic implications for\npharmacotherapy: A brief overview of the research. Nutrients14, 3335. https:\/\/doi.org\/10.3390\/nu14163335 (2022).","journal-title":"Nutrients"},{"key":"73278_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.31069\/japsr.v5i2.03","volume":"5","author":"V Sati","year":"2022","unstructured":"Sati, V., Jauhari, R., Rao, N., Godiyal, P. & Babbar, A.\nMelatonin: Role in the prophylaxis of migraine. J. Appl.\nPharm. Sci. Res.5, 17\u201327\n(2022).","journal-title":"J. Appl. Pharm. Sci. Res."},{"issue":"Suppl 1","key":"73278_CR26","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1016\/j.pain.2013.07.021","volume":"154","author":"R Noseda","year":"2013","unstructured":"Noseda, R. & Burstein, R. Migraine pathophysiology: Anatomy\nof the trigeminovascular pathway and associated neurological symptoms, cortical\nspreading depression, sensitization, and modulation of pain. Pain154(Suppl 1),\nS44-53. https:\/\/doi.org\/10.1016\/j.pain.2013.07.021 (2013).","journal-title":"Pain"},{"issue":"Suppl 1","key":"73278_CR27","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1111\/j.1526-4610.2006.00483.x","volume":"46","author":"PL Durham","year":"2006","unstructured":"Durham, P. L. Calcitonin gene-related peptide (CGRP) and migraine.\nHeadache46(Suppl 1), S3-8. https:\/\/doi.org\/10.1111\/j.1526-4610.2006.00483.x (2006).","journal-title":"Headache"},{"key":"73278_CR28","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2165\/00023210-200620050-00001","volume":"20","author":"B Vogler","year":"2006","unstructured":"Vogler, B., Rapoport, A. M., Tepper, S. J., Sheftell, F. &\nBigal, M. E. Role of melatonin in the pathophysiology of migraine: Implications\nfor treatment. CNS Drugs20, 343\u2013350. https:\/\/doi.org\/10.2165\/00023210-200620050-00001 (2006).","journal-title":"CNS Drugs"},{"key":"73278_CR29","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s13760-017-0803-x","volume":"117","author":"M Ansari","year":"2017","unstructured":"Ansari, M., Karkhaneh, A., Kheirollahi, A., Emamgholipour, S.\n& Rafiee, M. H. The effect of melatonin on gene expression of calcitonin\ngene-related peptide and some proinflammatory mediators in patients with pure\nmenstrual migraine. Acta Neurol.\nBelg.117, 677\u2013685. https:\/\/doi.org\/10.1007\/s13760-017-0803-x (2017).","journal-title":"Acta Neurol. Belg."},{"key":"73278_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.11607\/ofph.3211","volume":"36","author":"HM Puliappadamb","year":"2022","unstructured":"Puliappadamb, H. M., Maiti, R., Mishra, A., Jena, M. &\nMishra, B. R. Efficacy and safety of melatonin as prophylaxis for migraine in\nadults: A meta-analysis. J. Oral Fac. Pain\nHeadache36, 207\u2013219. https:\/\/doi.org\/10.11607\/ofph.3211 (2022).","journal-title":"J. Oral Fac. Pain Headache"},{"key":"73278_CR31","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3233\/rnn-160704","volume":"35","author":"M Ebrahimi-Monfared","year":"2017","unstructured":"Ebrahimi-Monfared, M., Sharafkhah, M., Abdolrazaghnejad, A.,\nMohammadbeigi, A. & Faraji, F. Use of melatonin versus valproic acid in\nprophylaxis of migraine patients: A double-blind randomized clinical trial.\nRestor. Neurol. Neurosci.35, 385\u2013393. https:\/\/doi.org\/10.3233\/rnn-160704 (2017).","journal-title":"Restor. Neurol. Neurosci."},{"key":"73278_CR32","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/j.1749-6632.2000.tb05402.x","volume":"917","author":"RJ Reiter","year":"2000","unstructured":"Reiter, R. J., Calvo, J. R., Karbownik, M., Qi, W. & Tan, D.\nX. Melatonin and its relation to the immune system and inflammation. Ann. N. Y. Acad. Sci.917, 376\u2013386. https:\/\/doi.org\/10.1111\/j.1749-6632.2000.tb05402.x (2000).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"73278_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.885293","volume":"9","author":"SJ Li","year":"2022","unstructured":"Li, S. J. et al. Melatonin\ninhibits NF-\u03baB\/CREB\/Runx2 signaling and alleviates aortic valve\ncalcification. Front. Cardiovasc.\nMed.9, 885293. https:\/\/doi.org\/10.3389\/fcvm.2022.885293 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"73278_CR34","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s10787-022-01011-0","volume":"30","author":"A Mu\u00f1oz-Jurado","year":"2022","unstructured":"Mu\u00f1oz-Jurado, A. et al.\nMelatonin and multiple sclerosis: Antioxidant, anti-inflammatory and\nimmunomodulator mechanism of action. Inflammopharmacology30,\n1569\u20131596. https:\/\/doi.org\/10.1007\/s10787-022-01011-0 (2022).","journal-title":"Inflammopharmacology"},{"key":"73278_CR35","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12974-022-02477-z","volume":"19","author":"J Huang","year":"2022","unstructured":"Huang, J. et al. Melatonin, an\nendogenous hormone, modulates Th17 cells via the reactive-oxygen\nspecies\/TXNIP\/HIF-1\u03b1 axis to alleviate autoimmune uveitis. J. Neuroinflamm.19, 124. https:\/\/doi.org\/10.1186\/s12974-022-02477-z (2022).","journal-title":"J. Neuroinflamm."},{"key":"73278_CR36","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1002\/pros.24214","volume":"81","author":"J Chen","year":"2021","unstructured":"Chen, J. et al. Melatonin\nattenuates prostatic inflammation and pelvic pain via Sirt1-dependent inhibition\nof the NLRP3 inflammasome in an EAP mouse model. Prostate81, 1179\u20131190. https:\/\/doi.org\/10.1002\/pros.24214 (2021).","journal-title":"Prostate"},{"key":"73278_CR37","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1177\/0333102414539057","volume":"35","author":"L Neeb","year":"2015","unstructured":"Neeb, L. et al. Corticosteroids\nalter CGRP and melatonin release in cluster headache episodes. Cephalalgia35,\n317\u2013326. https:\/\/doi.org\/10.1177\/0333102414539057 (2015).","journal-title":"Cephalalgia"},{"key":"73278_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018","unstructured":"Headache Classification Committee of the International Headache\nSociety (IHS). The international classification of headache disorders 3rd\nedition. Cephalalgia38, 1\u2013211. https:\/\/doi.org\/10.1177\/0333102417738202 (2018).","journal-title":"Cephalalgia"},{"key":"73278_CR39","doi-asserted-by":"publisher","unstructured":"The international classification of headache disorders, 3rd edition\n(beta version). Cephalalgia33, 629-808 (2013). https:\/\/doi.org\/10.1177\/0333102413485658","DOI":"10.1177\/0333102413485658"},{"key":"73278_CR40","unstructured":"(2021), G. D. Bioanalytical Method\nValidation Guidance for Industry (FDA, 2018)."}],"updated-by":[{"DOI":"10.1038\/s41598-025-87562-y","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"record-id":"62406"},{"DOI":"10.1038\/s41598-025-87562-y","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73278-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73278-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73278-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T04:51:42Z","timestamp":1738126302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73278-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,2]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["73278"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-73278-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,2]]},"assertion":[{"value":"1 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-025-87562-y","URL":"https:\/\/doi.org\/10.1038\/s41598-025-87562-y","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22883"}}